
OliX Pharmaceuticals to Conduct Business Meetings with Potential Partners at 2022 BIO International Convention
SUWON, South Korea–(BUSINESS WIRE)–#2022BIOInternationalConvention—OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company’s management will participate in one-on-one partnering […]



